Colossal Biosciences – the company behind an ambitious, Jurassic Park-style effort to revive extinct bird and mammal species such as the thylacine, dodo and woolly mammoth – said it had raised ...

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Big changes are coming this year, and Colossal HQ is moving to an exciting new location. We need your help to lighten our load. Enjoy 20% off almost everything in the Colossal Shop and snag the final ...

Imagine observing this leviathan gracefully navigating the depths – a living testament to the wonders of marine life. Playful Giants: Behaviors of the Colossal Beluga Contrary to their imposing size, ...

It would take decades, however, before we finally came face to face with the colossal squid. Under sombre, mausoleum lighting at the Museum of New Zealand Te Papa Tongarewa rests a monster.

Dallas-based Colossal Biosciences is making history—again. The world’s first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, has become ...

DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in a Series C financing by TWG Global, a diversified holding company with ...

Dallas-based Colossal has put itself into a unique class of businesses: a decacorn. There are only 75 such privately-held companies—those holding a valuation of $10 billion or more—on the ...

Colossal, a leading Texas-based biosciences company working to combat environmental dangers and revive extinct species, has reached a new funding milestone that it says will accelerate its pioneering ...